This F1000 commentary reviews a landmark Ahmed Versus Baerveldt (AVB) study that compares the safety and efficacy of the 2 most popular aqueous shunts. Faculty of 1000
Category: News
ACT treats fourth patient in U.S. clinical trial for Stargardt’s Macular Dystrophy
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in its U.S. clinical trial for Stargardt’s Macular Dystrophy (SMD).
Exposure To Chemical In Drinking Water In The Womb And Early Childhood May Affect Vision
Prenatal and early childhood exposure to the chemical solvent tetrachloroethylene (PCE) found in drinking water may be associated with long-term visual impairments, particularly in the area of color discrimination, a new study led by Boston University …
Retina Transplantation Improved By Manipulating Recipient Retinal Microenvironment
A research team in the United Kingdom has found that insulin-like growth factor (IGF1) impacts cell transplantation of photoreceptor precursors by manipulating the retinal recipient microenvironment, enabling better migration and integration of the cel…
Manipulating retinal recipient microenvironment impacts photoreceptor cell transplantation
A research team in the United Kingdom has found that insulin-like growth factor (IGF1) impacts cell transplantation of photoreceptor precursors by manipulating the retinal recipient microenvironment, enabling better migration and integration of the cel…
Prenatal and early childhood exposure to PCE may be associated with long-term visual impairments
Prenatal and early childhood exposure to the chemical solvent tetrachloroethylene (PCE) found in drinking water may be associated with long-term visual impairments, particularly in the area of color discrimination, a new study led by Boston University …
Corneal graft survival better after ALK than PK
Patients treated with anterior lamellar keratoplasty for tectonic indications have better physiologic graft survival outcomes than their counterparts treated with penetrating keratoplasty, despite the former procedure raising the risk for anatomic fail…
Ranibizumab and Bevacizumab Equally Effective Against AMD
The drugs were equally effective in eliminating the fluid associated with neovascular AMD in a randomized controlled trial; monthly dosing was more effective than as-needed dosing. Medscape Medical News
Retinal Disease: Advances in Treatment
Drs. Roger Steinert and Barry Kuppermann review the latest study results in retinal disease as presented during ARVO 2012. How will they translate into clinical practice? Medscape Ophthalmology
VEGF Inhibitors for Macular Degeneration Not Tied to Stroke
Vascular endothelial growth factor (VEGF) inhibitors used for age-related macular degeneration did not increase patients’ risk of stroke in a population-based study in Canada. Reuters Health Information
Customer Survey Shows High Satisfaction Rate with ReVision Optics’ Near Vision Inlay for Presbyopia
LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics®, Inc. (RVO), a leader in implantable inlay technology to treat presbyopia, reported a high level of satisfaction from a group of 58 patients treated for presbyopia at the Ultralase Clinics in the …
Hope For Treatment Of Hearing Loss With Usher Syndrome III
A new study published in the July 11 issue of the Journal of Neuroscience details the development of the first mouse model engineered to carry the most common mutation in Usher syndrome III causative gene (Clarin-1) in North America. Further, the resea…
Daily IOP changes undermine measurement, medication
Day-to-day variability significantly undermines the precision of intraocular pressure measurement and the estimation of medication effectiveness in glaucoma patients, report researchers.Licensed from Medwire news with permission from Springer Healthcar…
Glaucoma Co-management: Interprofessional Agreement
How can ophthalmologists and optometrists work together to ensure that glaucoma patients receive the best and most comprehensive care? Eye
Ampio announces results from Optina trial on DME
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead …
Help For The Blind From Device Converting Images Into Music
Sensory substitution devices (SSDs) use sound or touch to help the visually impaired perceive the visual scene surrounding them. The ideal SSD would assist not only in sensing the environment but also in performing daily activities based on this input….
Sharp Rise in Adult Eye Diseases as Baby Boomers Age
Report outlines the estimated prevalence of age-related eye diseases in the United States. Data show an estimated 89% increase in diabetic retinopathy among people age 40 and older since 2000. Medscape Medical News
Corneal Crosslinking: What We Know, What We Don’t Know
Dr. Roger Steinert delves into corneal crosslinking, a subject getting a lot of attention recently. What is it we know, don’t know, and hope to know about this novel procedure? Medscape Ophthalmology
Fireworks Cause Eye Abrasions, Not Lens Damage (CME/CE)
(MedPage Today) — Injuries to the eye caused by fireworks mostly involve the cornea and do not appear to be associated with blast pressures, but rather result from detritus projected into the eye, a simulated experiment found.
Is Failed ‘Big Bubble’ DALK Really as Good?
And what is the most reasonable alternative when ‘big bubble’ is not achieved? Medscape Ophthalmology